PFIZER INC. V. TEVA PHARMACEUTICALS USA, INC. , No. 12-1576 (Fed. Cir. 2012)
Annotate this Case
Download PDF
Case: 12-1576 Document: 70 Page: 1 Filed: 10/17/2012 NOTE: This order is nonprecedential. mtntteb ~tates <!Court of ~peaIs for tbe jfeberaI <!Ctreutt PFIZER INC., WARNER-LAMBERT COMPANYLLC, AND C.P. PHARMACEUTICALS INTERNATIONAL C.V., Plaintiffs-Appellees, AND NORTHWESTERN UNIVERSITY, Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellants, AND LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants, AND ACTAVIS, INC. AND ACTAVIS ELIZABETH, LLC, Defendants-Appellants, AND COBALT LABORATORIES, INC. AND COBALT PHARMACEUTICALS, INC., Defendants-Appellants, Case: 12-1576 Document: 70 Page: 2 Filed: 10/17/2012 PFIZER INC. V. TEVA PHARMACEUTICALS USA 2 AND SUN PHARMA GLOBAL, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, INC., Defendants-Appellants, AND WOCKHARDT LIMITED AND WOCKHARDT USA, LLC, Defendants-Appellants, AND ALPHAPHARM PTY. LTD. AND MYLAN PHARMACEUTICALS, INC., Defendants-Appellants. 2012-1576, -1601, -1602, -1603, -1604, -1605, -1607 Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0307, Chief Judge Gregory M. Sleet. ON MOTION ORDER The parties jointly move for an extension of 31 days, until November 19, 2012, for the appellants to file their principal briefs and 46 days, until February 15, 2013, for appellees to file their responsive brief. Case: 12-1576 Document: 70 Page: 3 Filed: 10/17/2012 PFIZER INC. V. TEVA PHARMACEUTICALS USA Upon consideration thereof, IT Is ORDERED THAT: The motion is granted. FOR THE COURT /s/ Jan Horbaly Jan Horbaly Clerk s27 3
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
